NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
Oak Ridge National Lab Advances AI Infrastructure for Genesis Mission
Oak Ridge is helping build the Genesis Mission’s AI-powered scientific ecosystem to accelerate discovery and collaboration.
17m listen -
Endpoint Visibility, Faster Patching Key to Federal Cybersecurity Amid Calls for Speed
Federal agencies face pressure to accelerate patching, improve endpoint visibility and streamline cybersecurity operations.
16m watch -
HHS Identifies Three Priorities for Clinical AI Adoption
Officials outlined efforts for implementation support, coordination and evaluation standards with new AI regulatory proposals expected soon.
5m read -
DOT Pushes Toward Passwordless Future as Zero-Trust Matures
Enterprise Security Architect Austin Clark says zero-trust adoption is accelerating as users embrace faster, more secure authentication experiences.
10m watch
